FDA Inspection 1079073 — Lucasti Christopher, D.O.
The FDA completed an inspection of Lucasti Christopher, D.O. on Jan 25, 2019 in Somers Point, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 25, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Somers Point, NJ (United States)
Additional details
Clinical Investigator (CI)